Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-18T01:36:54.537Z Has data issue: false hasContentIssue false

Chapter 11 - Metabolic and inherited connective tissue disorders involving the lung

Published online by Cambridge University Press:  05 June 2014

By
Gail Amir  and
Annick Raas-Rothschild
Edited by
Philip Hasleton  and
Douglas B. Flieder
Philip Hasleton
Affiliation:
University of Manchester
Douglas B. Flieder
Affiliation:
Fox Chase Cancer Center, Philadelphia
Get access

Summary

Introduction

Lung involvement presenting in the course of metabolic disorders is usually overshadowed by features of the underlying disease. Pulmonary involvement is rarely the initial presenting feature. This constitutes a diagnostic challenge, particularly in adults, since the changes on biopsy are frequently nonspecific and a diagnosis of metabolic lung disease may not be considered. The pulmonary pathologist needs to be aware of the repertoire of lung pathology in these diseases to facilitate early diagnosis. This is ever more important, not only for genetic counseling but also for prompt therapy.

Lysosomal storage diseases

Lysosomal storage diseases constitute a group of inherited disorders characterized by lack of a protein essential for normal lysosomal function. As a consequence, substrate accumulates in cells of various organs. Marked phenotypic heterogeneity characterizes many of these diseases with regard to age of onset, severity of symptoms and organs affected including the central nervous system (CNS). In many metabolic diseases the lungs are involved and in some cases the pulmonary involvement is significant. These usually present with interstitial infiltration, airways obstruction or pulmonary hypertension.

Type
Chapter
Information
Spencer's Pathology of the Lung , pp. 409 - 438
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Grabowski, GA, Petsko, GA, Kolodny, EH.Gaucher disease – revised July 2010, Chapter 146. In Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, Vogelstein, B, eds. Metabolic and Molecular Bases of Inherited disease – OMMBID. New York: McGraw-Hill, 2006.Google Scholar
Weinreb, NJ, Andersson, HC, Banikazemi, M, et al. Prevalence of type 1 Gaucher disease in the United States. Arch Intern Med 2008;168:326–7; author reply 327–8.CrossRefGoogle ScholarPubMed
Mehta, A.Epidemiology and natural history of Gaucher's disease. Eur J Intern Med 2006;17 Suppl:S2–5.CrossRefGoogle ScholarPubMed
Dreborg, S, Erikson, A, Hagberg, B.Gaucher disease – Norrbottnian type. I. General clinical description. Eur J Pediatr 1980;133:107–18.CrossRefGoogle ScholarPubMed
Hruska, KS, LaMarca, ME, Scott, CR, Sidransky, E.Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 2008;29:567–83.CrossRefGoogle Scholar
Beutler, E.Gaucher disease: multiple lessons from a single gene disorder. Acta Paediatr 2006;95:103–9.CrossRefGoogle ScholarPubMed
Santamaria, F, Parenti, G, Guidi, G, et al. Pulmonary manifestations of Gaucher disease: an increased risk for L444P homozygotes?Am J Respir Crit Care Med 1998;157:985–9.CrossRefGoogle ScholarPubMed
Kerem, E, Elstein, D, Abrahamov, A, et al. Pulmonary function abnormalities in type I Gaucher disease. Eur Respir J 1996;9:340–5.CrossRefGoogle ScholarPubMed
Goitein, O, Elstein, D, Abrahamov, A, et al. Lung involvement and enzyme replacement therapy in Gaucher's disease. QJM 2001;94:407–15.CrossRefGoogle ScholarPubMed
Elstein, D, Klutstein, MW, Lahad, A, et al. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet 1998;351:1544–6.CrossRefGoogle ScholarPubMed
Mistry, PK, Sirrs, S, Chan, A, et al. Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab 2002;77:91–8.CrossRefGoogle ScholarPubMed
Mignot, C, Doummar, D, Maire, I, De Villemeur, TB.Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev 2006;28:39–48.CrossRefGoogle ScholarPubMed
Takahashi, T, Yoshida, Y, Sato, W, et al. Enzyme therapy in Gaucher disease type 2: an autopsy case. Tohoku J Exp Med 1998;186:143–9.CrossRefGoogle Scholar
Kraoua, I, Sedel, F, Caillaud, C, et al. A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients. Brain Dev 2011;33:131–9.CrossRefGoogle ScholarPubMed
Aydin, K, Karabulut, N, Demirkazik, F, Arat, A.Pulmonary involvement in adult Gaucher's disease: high resolution CT appearance. Br J Radiol 1997;70:93–5.CrossRefGoogle ScholarPubMed
Amir, G, Ron, N.Pulmonary pathology in Gaucher's disease. Hum Pathol 1999;30:666–70.CrossRefGoogle ScholarPubMed
Lee, RE, Yousem, SA.The frequency and type of lung involvement in patients with Gaucher's disease. Lab Invest [Abstract] 1988;58:54Google Scholar
Theise, ND, Ursell, PC.Pulmonary hypertension and Gaucher's disease: logical association or mere coincidence?Am J Pediatr Hematol Oncol 1990;12:74–6.CrossRefGoogle ScholarPubMed
Smith, RL, Hutchins, GM, Sack, GH, Ridolfi, RL.Unusual cardiac, renal and pulmonary involvement in Gaucher's disease. Intersitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization. Am J Med 1978;65:352–60.CrossRefGoogle ScholarPubMed
Roberts, WC, Fredrickson, DS.Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis. Circulation 1967;35:783–9.CrossRefGoogle ScholarPubMed
Prows, CA, Sanchez, N, Daugherty, C, Grabowski, GA.Gaucher disease: enzyme therapy in the acute neuronopathic variant. Am J Med Genet 1997;71:16–21.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Bove, KE, Daugherty, C, Grabowski, GA.Pathological findings in Gaucher disease type 2 patients following enzyme therapy. Hum Pathol 1995;26:1040–5.CrossRefGoogle ScholarPubMed
Tsai, P, Lipton, JM, Sahdev, I, et al. Allogenic bone marrow transplantation in severe Gaucher disease. Pediatr Res 1992;31:503–7.CrossRefGoogle ScholarPubMed
Wilson, ER, Barton, NW, Barranger, JA.Vascular involvement in type 3 neuronopathic Gaucher's disease. Arch Pathol Lab Med 1985;109:82–4.Google ScholarPubMed
Carson, KF, Williams, CA, Rosenthal, DL, et al. Bronchoalveolar lavage in a girl with Gaucher's disease. A case report. Acta Cytol 1994;38:597–600.Google Scholar
Zimran, A, Elstein, D.Gaucher disease and the clinical experience with substrate reduction therapy. Philos Trans R Soc Lond B Biol Sci 2003;358:961–6.CrossRefGoogle ScholarPubMed
Elstein, D, Nir, A, Klutstein, M, Rudensky, B, Zimran, A.C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease. Blood Cells Mol Dis 2005;34:201–5.CrossRefGoogle ScholarPubMed
Dunn, P, Kuo, MC, Sun, CF.Pseudo-Gaucher cells in mycobacterial infection: a report of two cases. J Clin Pathol 2005;58:1113–4.CrossRefGoogle ScholarPubMed
Valerdiz-Casasola, S, Velasco-Garcia, R, Rodriguez-Rodriguez, R.[Wolman's disease. Pulmonary storage of lipids]. An Esp Pediatr 1997;47:427–8.Google Scholar
Ionescu, DN, Pierson, DM, Qing, G, et al. Pulmonary crystal-storing histiocytoma. Arch Pathol Lab Med 2005;129:1159–63.Google ScholarPubMed
Fairweather, PM, Williamson, R, Tsikleas, G.Pulmonary extranodal marginal zone lymphoma with massive crystal storing histiocytosis. Am J Surg Pathol 2006;30:262–7.CrossRefGoogle ScholarPubMed
Prasad, ML, Charney, DA, Sarlin, J, Keller, SM.Pulmonary immunocytoma with massive crystal storing histiocytosis: a case report with review of literature. Am J Surg Pathol 1998;22:1148–53.CrossRefGoogle ScholarPubMed
Jones, D, Renshaw, AA.Recurrent crystal-storing histiocytosis of the lung in a patient without a clonal lymphoproliferative disorder. Arch Pathol Lab Med 1996;120:978–80.Google Scholar
Egan, AJ, Boardman, LA, Tazelaar, HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999;23:17–26.CrossRefGoogle ScholarPubMed
Kelly, CA, Egan, M, Rawlinson, J.Whipple's disease presenting with lung involvement. Thorax 1996;51:343–4.CrossRefGoogle ScholarPubMed
Altarescu, G, Hill, S, Wiggs, E, et al. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. J Pediatr 2001;138:539–47.CrossRefGoogle ScholarPubMed
Sawkar, AR, D'Haeze, W, Kelly, JW.Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease. Cell Mol Life Sci 2006;63:1179–92.CrossRefGoogle ScholarPubMed
Somaraju, UR, Tadepalli, K. Hematopoietic stem cell transplantation for Gaucher disease. Cochrane Database Syst Rev 2008:CD006974.
Rao, AR, Parakininkas, D, Hintermeyer, M, Segura, AD, Rice, TB.Bilateral lung transplant in Gauchers type-1 disease. Pediatr Transplant 2005;9:239–43.CrossRefGoogle ScholarPubMed
Schuchman, EH, Miranda, SR.Niemann-Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing. Genet Test 1997;1:13–9.Google ScholarPubMed
Schuchman, EH.The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis 2007;30:654–63.CrossRefGoogle ScholarPubMed
McGovern, MM, Aron, A, Brodie, SE, Desnick, RJ, Wasserstein, MP.Natural history of Type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology 2006;66:228–32.CrossRefGoogle ScholarPubMed
Wasserstein, MP, Desnick, RJ, Schuchman, EH, et al. The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study. Pediatrics 2004;114:e672–7.CrossRefGoogle ScholarPubMed
Uyan, ZS, Karadag, B, Ersu, R, et al. Early pulmonary involvement in Niemann-Pick type B disease: lung lavage is not useful. Pediatr Pulmonol 2005;40:169–72.CrossRefGoogle Scholar
Lever, AM, Ryder, JB.Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax 1983;38:873–4.CrossRefGoogle Scholar
McGovern, MM, Wasserstein, MP, Giugliani, R, et al. A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B. Pediatrics 2008;122:e341–9.CrossRefGoogle ScholarPubMed
Mendelson, DS, Wasserstein, MP, Desnick, RJ, et al. Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing. Radiology 2006;238:339–45.CrossRefGoogle ScholarPubMed
Nicholson, AG, Florio, R, Hansell, DM, et al. Pulmonary involvement by Niemann-Pick disease. A report of six cases. Histopathology 2006;48:596–603.CrossRefGoogle ScholarPubMed
Chung, MJ, Lee, KS, Franquet, T, et al. Metabolic lung disease: imaging and histopathologic findings. Eur J Radiol 2005;54:233–45.CrossRefGoogle ScholarPubMed
Simpson, WL, Mendelson, D, Wasserstein, MP, McGovern, MM.Imaging manifestations of Niemann-Pick disease type B. AJR Am J Roentgenol 2010;194:W12–9.CrossRefGoogle ScholarPubMed
Baldi, BG, Santana, AN, Takagaki, TY, et al. Lung cyst: an unusual manifestation of Niemann-Pick disease. Respirology 2009;14:134–6.CrossRefGoogle ScholarPubMed
Schuchman, EH.Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2004.Google Scholar
Minai, OA, Sullivan, EJ, Stoller, JK.Pulmonary involvement in Niemann-Pick disease: case report and literature review. Respir Med 2000;94:1241–51.CrossRefGoogle ScholarPubMed
Ferretti, GR, Lantuejoul, S, Brambilla, E, Coulomb, M.Case report. Pulmonary involvement in Niemann-Pick disease subtype B: CT findings. J Comput Assist Tomogr 1996;20:990–2.CrossRefGoogle ScholarPubMed
Guillemot, N, Troadec, C, de Villemeur, TB, Clement, A, Fauroux, B.Lung disease in Niemann-Pick disease. Pediatr Pulmonol 2007;42:1207–14.CrossRefGoogle ScholarPubMed
Boustany, RN, Kaye, E, Alroy, J.Ultrastructural findings in skin from patients with Niemann-Pick disease, type C. Pediatr Neurol 1990;6:177–83.CrossRefGoogle ScholarPubMed
Vanier, MT, Boue, J, Dumez, Y.Niemann-Pick disease type B: first-trimester prenatal diagnosis on chorionic villi and biochemical study of a foetus at 12 weeks of development. Clin Genet 1985;28:348–54.CrossRefGoogle ScholarPubMed
Dhami, R, Passini, MA, Schuchman, EH.Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice. Mol Ther 2006;13:556–64.CrossRefGoogle ScholarPubMed
Dhami, R, He, X, Gordon, RE, Schuchman, EH.Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase – deficient mouse model of Niemann-Pick disease. Lab Invest 2001;81:987–99.CrossRefGoogle ScholarPubMed
Ikegami, M, Dhami, R, Schuchman, EH.Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am J Physiol Lung Cell Mol Physiol 2003;284:L518–25.CrossRefGoogle Scholar
Nicholson, AG, Wells, AU, Hooper, J, et al. Successful treatment of endogenous lipoid pneumonia due to Niemann-Pick Type B disease with whole-lung lavage. Am J Respir Crit Care Med 2002;165:128–31.CrossRefGoogle ScholarPubMed
Victor, S, Coulter, JB, Besley, GT, et al. Niemann-Pick disease: sixteen-year follow-up of allogeneic bone marrow transplantation in a type B variant. J Inherit Metab Dis 2003;26:775–85.CrossRefGoogle Scholar
Mylla Neto, G, Costa, R, Fernandes, P, et al. Niemann-Pick disease in adult: report of a case surgically treated. Rev Hosp Clin Fac Med Univ Sao Paulo 1983;38:83.Google ScholarPubMed
Miranda, SR, He, X, Simonaro, CM, et al. Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J 2000;14:1988–95.CrossRefGoogle Scholar
Ziegler, RJ, Brown, C, Barbon, CM, et al. Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease. Mol Genet Metab 2009;97:35–42.CrossRefGoogle ScholarPubMed
Miranda, SR, Erlich, S, Friedrich, VL, Gatt, S, Schuchman, EH.Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease. Gene Ther 2000;7:1768–76.CrossRefGoogle Scholar
Patterson, MC, Suzuki, K, Morris, JA, Carstea, E, Neufeld, EB.Niemann-Pick type C: a lipid trafficking disorder, Chapter 145. In Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, Vogelstein, B, eds. Metabolic and Molecular Bases of Inherited Disease (OMMBID). New York: McGraw-Hill, 2006.Google Scholar
Vance, JE.Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett 2006;580:5518–24.CrossRefGoogle ScholarPubMed
Wenger, DA, Barth, G, Githens, JH.Nine cases of sphingomyelin lipidosis, a new variant in Spanish-American Children. Juvenile variant of Niemann-Pick Disease with foamy and sea-blue histiocytes. Am J Dis Child 1977;131:955–61.CrossRefGoogle ScholarPubMed
Crocker, AC.The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J Neurochem 1961;7:69–80.CrossRefGoogle ScholarPubMed
Vanier, MT, Millat, G.Niemann-Pick disease type C. Clin Genet 2003;64:269–81.CrossRefGoogle ScholarPubMed
Morisot, C, Millat, G, Coeslier, A, et al. [Fatal neonatal respiratory distress in Niemann-Pick C2 and prenatal diagnosis with mutations in gene HE1/NPC2]. Arch Pediatr 2005;12:434–7.CrossRefGoogle Scholar
Elleder, M, Houstkova, H, Zeman, J, Ledvinova, J, Poupetova, H.Pulmonary storage with emphysema as a sign of Niemann-Pick type C2 disease (second complementation group). Report of a case. Virchows Arch 2001;439:206–11.CrossRefGoogle ScholarPubMed
Schofer, O, Mischo, B, Puschel, W, Harzer, K, Vanier, MT.Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group. Eur J Pediatr 1998;157:45–9.CrossRefGoogle ScholarPubMed
Kovesi, TA, Lee, J, Shuckett, B, et al. Pulmonary infiltration in Niemann-Pick disease type C. J Inherit Metab Dis 1996;19:792–3.CrossRefGoogle ScholarPubMed
Bjurulf, B, Spetalen, S, Erichsen, A, et al. Niemann-Pick disease type C2 presenting as fatal pulmonary alveolar lipoproteinosis: morphological findings in lung and nervous tissue. Med Sci Monit 2008;14:CS71–5.Google ScholarPubMed
Verot, L, Chikh, K, Freydiere, E, et al. Niemann-Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2. Clin Genet 2007;71:320–30.CrossRefGoogle ScholarPubMed
Lloyd-Evans, E, Morgan, AJ, He, X, et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 2008;14:1247–55.CrossRefGoogle ScholarPubMed
Erickson, RP.A first therapy for Niemann-Pick C. Lancet Neurol 2007;6:748–9.CrossRefGoogle ScholarPubMed
Hsu, YS, Hwu, WL, Huang, SF, et al. Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant 1999;24:103–7.CrossRefGoogle ScholarPubMed
Vanier, MT.Niemann-Pick disease type C. Orphanet J Rare Dis 2010;5:16.CrossRefGoogle ScholarPubMed
Meikle, PJ, Hopwood, JJ, Clague, AE, Carey, WF.Prevalence of lysosomal storage disorders. JAMA 1999;281:249–54.CrossRefGoogle ScholarPubMed
Eng, CM, Germain, DP, Banikazemi, M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med 2006;8:539–48.CrossRefGoogle ScholarPubMed
Zarate, YA, Hopkin, RJ.Fabry's disease. Lancet 2008;372:1427–35.CrossRefGoogle ScholarPubMed
Magage, S, Lubanda, JC, Susa, Z, et al. Natural history of the respiratory involvement in Anderson-Fabry disease. J Inherit Metab Dis 2007;30:790–9.CrossRefGoogle ScholarPubMed
Eng, C, Ioannou, YA, Desnick, RJ.Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2004.Google Scholar
Brown, LK, Miller, A, Bhuptani, A, et al. Pulmonary involvement in Fabry disease. Am J Respir Crit Care Med 1997;155:1004–10.CrossRefGoogle ScholarPubMed
Rosenberg, DM, Ferrans, VJ, Fulmer, JD, et al. Chronic airflow obstruction in Fabry's disease. Am J Med 1980;68:898–905.CrossRefGoogle ScholarPubMed
Bartimmo, EE, Guisan, M, Moser, KM.Pulmonary involvement in Fabry's disease: a reappraisal follow-up of a San Diego kindred and review of literature. Am J Med 1972;53:755–64.CrossRefGoogle Scholar
Kim, W, Pyeritz, RE, Bernhardt, BA, Casey, M, Litt, HI.Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy. Am J Med Genet A 2007;143:377–81.CrossRefGoogle ScholarPubMed
Wang, RY, Abe, JT, Cohen, AH, Wilcox, WR.Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage. J Inherit Metab Dis 2008;31:5369–74.CrossRefGoogle ScholarPubMed
Smith, P, Heath, D, Rodgers, B, Helliwell, T.Pulmonary vasculature in Fabry's disease. Histopathology 1991;19:567–9.CrossRefGoogle ScholarPubMed
Bagdade, JD, Parker, F, Ways, PO, et al. Fabry's disease. A correlative clinical, morphologic, and biochemical study. Lab Invest 1968;18:681–8.Google ScholarPubMed
Magage, S, Lubanda, JC, Germain, DP, Bultas, J, Karetova, D, Linhart, A.Respiratory involvement in patients with Fabry disease. Med Sci (Paris) 2005;11S:37–9.CrossRefGoogle Scholar
Kelly, MM, Leigh, R, McKenzie, R, et al. Induced sputum examination: diagnosis of pulmonary involvement in Fabry's disease. Thorax 2000;55:720–1.CrossRefGoogle ScholarPubMed
Lidove, O, Bekri, S, Goizet, C, et al. [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up]. Presse Med 2007;36:1084–97.CrossRefGoogle Scholar
DeGraba, T, Azhar, S, Dignat-George, F, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol 2000;47:229–33.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Schaefer, E, Mehta, A, Gal, A.Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey. Acta Paediatr Suppl 2005;94:87–92; discussion 79.CrossRefGoogle ScholarPubMed
Banikazemi, M, Bultas, J, Waldek, S, et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med 2007;146:77–86.CrossRefGoogle ScholarPubMed
Korswagen, LA, Huizing, M, Simsek, S, Janssen, JJ, Zweegman, S.A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5. Eur J Haematol 2008;80:356–60.CrossRefGoogle Scholar
Huizing, M, Anikster, Y, Gahl, WA.Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic 2000;1:823–35.CrossRefGoogle ScholarPubMed
Witkop, CJ, Almadovar, C, Pineiro, B, Nunez Babcock, M.Hermansky-Pudlak syndrome (HPS). An epidemiologic study. Ophthalmic Paediatr Genet 1990;11:245–50.CrossRefGoogle Scholar
Schallreuter, KU, Frenk, E, Wolfe, LS, Witkop, CJ, Wood, JM.Hermansky-Pudlak syndrome in a Swiss population. Dermatology 1993;187:248–56.CrossRefGoogle Scholar
Poddar, RK, Coley, S, Pavord, S.Hermansky-Pudlak syndrome in a pregnant patient. Br J Anaesth 2004;93:740–2.CrossRefGoogle Scholar
Parker, MS, Rosado Shipley, W, de Christenson, ML, et al. The Hermansky-Pudlak syndrome. Ann Diagn Pathol 1997;1:99–103.CrossRefGoogle ScholarPubMed
Brantly, M, Avila, NA, Shotelersuk, V, et al. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest 2000;117:129–36.CrossRefGoogle ScholarPubMed
Huizing, M, Helip-Wooley, A, Westbroek, W, Gunay-Aygun, M, Gahl, WA.Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet 2008;9:359–86.CrossRefGoogle ScholarPubMed
Oh, J, Bailin, T, Fukai, K, et al. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 1996;14:300–6.CrossRefGoogle ScholarPubMed
Pierson, DM, Ionescu, D, Qing, G, et al. Pulmonary fibrosis in Hermansky-Pudlak syndrome. a case report and review. Respiration 2006;73:382–95.CrossRefGoogle ScholarPubMed
Avila, NA, Brantly, M, Premkumar, A, et al. Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 2002;179:887–92.CrossRefGoogle ScholarPubMed
Nakatani, Y, Nakamura, N, Sano, J, et al. Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 2000;437:304–13.CrossRefGoogle ScholarPubMed
Lederer, DJ, Kawut, SM, Sonett, JR, et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. J Heart Lung Transplant 2005;24:1697–9.CrossRefGoogle ScholarPubMed
Takahashi, K, Ishida, T, Ogura, G, et al. Diagnostic usefulness of bronchoalveolar lavage in Hermansky-Pudlak syndrome: a case with double lung cancers. Intern Med 2004;43:972–6.CrossRefGoogle ScholarPubMed
Garay, SM, Gardella, JE, Fazzini, EP, Goldring, RM.Hermansky-Pudlak syndrome. Pulmonary manifestations of a ceroid storage disorder. Am J Med 1979;66:737–47.CrossRefGoogle ScholarPubMed
Feng, L, Novak, EK, Hartnell, LM, et al. The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes. Blood 2002;99:1651–8.Google ScholarPubMed
Mahavadi, P, Korfei, M, Henneke, I, et al. Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia. Am J Respir Crit Care Med 2010;182:207–19.CrossRefGoogle ScholarPubMed
Osanai, K, Higuchi, J, Oikawa, R, et al. Altered lung surfactant system in a Rab38-deficient rat model of Hermansky-Pudlak syndrome. Am J Physiol Lung Cell Mol Physiol 2010;298:L243–51.CrossRefGoogle Scholar
Gahl, WA, Brantly, M, Troendle, J, et al. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 2002;76:234–42.CrossRefGoogle ScholarPubMed
Clarke, LA.The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med 2008;10:e1.CrossRefGoogle ScholarPubMed
Neufeld, EF, Muenzer, J.The mucopolysaccharidoses, Chapter 136. In Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, Vogelstein, B, eds. The Metabolic and Molecular Bases of Inherited Disease (OMMBID). New York: McGraw-Hill, 2006.Google Scholar
Moore, D, Connock, MJ, Wraith, E, Lavery, C.The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis 2008;3:24.CrossRefGoogle ScholarPubMed
Wraith, JE, Beck, M, Giugliani, R, et al. Initial report from the Hunter Outcome Survey. Genet Med 2008;10:508–16.CrossRefGoogle ScholarPubMed
Leighton, SE, Papsin, B, Vellodi, A, Dinwiddie, R, Lane, R.Disordered breathing during sleep in patients with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol 2001;58:127–38.CrossRefGoogle ScholarPubMed
Ashworth, JL, Biswas, S, Wraith, E, Lloyd, IC.Mucopolysaccharidoses and the eye. Surv Ophthalmol 2006;51:1–17.CrossRefGoogle ScholarPubMed
Belani, KG, Krivit, W, Carpenter, BL, et al. Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg 1993;28:403–8; discussion 8–10.CrossRefGoogle ScholarPubMed
Walker, RW, Darowski, M, Morris, P, Wraith, JE.Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia 1994;49:1078–84.CrossRefGoogle ScholarPubMed
Muenzer, J.Mucopolysaccharidoses. Adv Pediatr 1986;33:269–302.Google ScholarPubMed
Eggli, KD, Dorst, JP.The mucopolysaccharidoses and related conditions. Semin Roentgenol 1986;21:275–94.CrossRefGoogle ScholarPubMed
Resnick, JM, Whitley, CB, Leonard, AS, Krivit, W, Snover, DC.Light and electron microscopic features of the liver in mucopolysaccharidosis. Hum Pathol 1994;25:276–86.CrossRefGoogle ScholarPubMed
Shapiro, J, Strome, M, Crocker, AC.Airway obstruction and sleep apnea in Hurler and Hunter syndromes. Ann Otol Rhinol Laryngol 1985;94:458–61.CrossRefGoogle ScholarPubMed
Fujitani, T, Kimura, A, Inoue, K, Okada, S.Pathological and biochemical study in the adenoid of mucopolysaccharidosis II. Int J Pediatr Otorhinolaryngol 1985;10:205–12.CrossRefGoogle ScholarPubMed
Dekaban, AS, Constantopoulos, G.Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain. Acta Neuropathol 1977;39:1–7.CrossRefGoogle Scholar
Van Hoof, F.Mucopolysaccharidoses and mucolipidoses. J Clin Pathol Suppl (R Coll Pathol) 1974;8:64–93.CrossRefGoogle ScholarPubMed
Kurihara, M, Kumagai, K, Goto, K, Imai, M, Yagishita, S.Severe type Hunter's syndrome. Polysomnographic and neuropathological study. Neuropediatrics 1992;23:248–56.CrossRefGoogle ScholarPubMed
Dinwiddie, R, Sonnappa, S.Systemic diseases and the lung. Paediatr Respir Rev 2005;6:181–9.CrossRefGoogle ScholarPubMed
Lindsay, S, Reilly, WA, et al. Gargoylism; study of pathologic lesions and clinical review of 12 cases. Am J Dis Child 1948;76:239–306.CrossRefGoogle ScholarPubMed
Yoshimoto, T, Nakamuta, M, Kotoh, K, et al. An adult case with Hunter's syndrome presenting prominent hepatic failure: light and electron microscopic features of the liver. Intern Med 2006;45:1133–5.CrossRefGoogle ScholarPubMed
Martin, R, Beck, M, Eng, C, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008;121:e377–86.CrossRefGoogle Scholar
Fuller, M, Rozaklis, T, Ramsay, SL, Hopwood, JJ, Meikle, PJ.Disease-specific markers for mucopolysaccharidoses. Pediatr Res 2004;56(5):733–8.CrossRefGoogle ScholarPubMed
Kamin, W.Diagnosis and management of respiratory involvement in Hunter syndrome. Acta Paediatr Suppl 2008;97:57–60.CrossRefGoogle ScholarPubMed
Kakkis, ED, Muenzer, J, Tiller, GE, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344:182–8.CrossRefGoogle ScholarPubMed
Adachi, K, Chole, RA.Management of tracheal lesions in Hurler syndrome. Arch Otolaryngol Head Neck Surg 1990;116:1205–7.CrossRefGoogle ScholarPubMed
Steven Sims, H, Kempiners, JJ.Special airway concerns in patients with mucopolysaccharidoses. Respir Med 2007;101:1779–82.CrossRefGoogle ScholarPubMed
Aldenhoven, M, Boelens, JJ, de Koning, TJ.The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 2008;14:485–98.CrossRefGoogle ScholarPubMed
Wraith, JE, Clarke, LA, Beck, M, et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 2004;144:581–8.CrossRefGoogle Scholar
Harmatz, P, Yu, ZF, Giugliani, R, et al. Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis 2010;33:51–60.CrossRefGoogle ScholarPubMed
Muenzer, J, Wraith, JE, Clarke, LA.Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009;123:19–29.CrossRefGoogle ScholarPubMed
Clarke, LA.Idursulfase for the treatment of mucopolysaccharidosis II. Expert Opin Pharmacother 2008;9:311–7.CrossRefGoogle ScholarPubMed
Herati, RS, Ma, X, Tittiger, M, et al. Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice. J Gene Med 2008;10:972–82.CrossRefGoogle ScholarPubMed
Okada, S, O'Brien, JS.Generalized gangliosidosis: beta-galactosidase deficiency. Science 1968;160:1002–4.CrossRefGoogle ScholarPubMed
Hakozaki, H, Takahashi, K, Naito, M, et al. Gaucher-like cells in juvenile GM1-gangliosidosis and in beta-thalassemia – a histochemical and ultrastructural observation. Acta Pathol Jpn 1979;29:303–18.Google ScholarPubMed
Mihatsch, MJ, Ohnacker, H, Riede, UN, et al. GM1-gangliosidoses. II. Morphological aspects and review of the literature. Helv Paediatr Acta 1973;28:521–42.Google ScholarPubMed
Gonatas, NK, Gonatas, J.Ultrastructural and biochemical observations on a case of systemic late infantile lipidosis and its relationship to Tay-Sachs disease and gargoylism. J Neuropathol Exp Neurol 1965;24:318–40.CrossRefGoogle ScholarPubMed
Landing, BH, Silverman, FN, Craig, JM, et al. Familial neurovisceral lipidosis. An analysis of eight cases of a syndrome previously reported as “Hurler-variant,” “pseudo-Hurler,” and “Tay-Sachs disease with visceral involvement”. Am J Dis Child 1964;108:503–22.CrossRefGoogle ScholarPubMed
Matsumoto, T, Matsumori, H, Taki, T, Takagi, T, Fukuda, Y.Infantile GM1-gangliosidosis with marked manifestation of lungs. Acta Pathol Jpn 1979;29:269–76.Google ScholarPubMed
Folkerth, RD, Alroy, J, Bhan, I, Kaye, EM.Infantile G(M1) gangliosidosis: complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination. Pediatr Dev Pathol 2000;3:73–86.CrossRefGoogle Scholar
Shield, JP, Stone, J, Steward, CG.Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis. J Inherit Metab Dis 2005;28:797–8.CrossRefGoogle Scholar
Clarke, JT, Ozere, RL, Krause, VW.Early infantile variant of Krabbe globoid cell leucodystrophy with lung involvement. Arch Dis Child 1981;56:640–2.CrossRefGoogle ScholarPubMed
Suzuki, K, Suzuki, Y, Suzuki, K, Wegener, DA.Galactosylcermide lipidosis: globiod cell leukodystrophy (Krabbe disease), Chapter 147. In Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, Vogelstein, B, eds. The Metabolic and Molecular Basis of Inherited Disease (OMMBID). New York: McGraw-Hill, 2006.Google Scholar
Escolar, ML, Poe, MD, Provenzale, JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005;352:2069–81.CrossRefGoogle ScholarPubMed
Krivit, W, Shapiro, EG, Peters, C, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998;338:1119–26.CrossRefGoogle ScholarPubMed
Hirschhorn, R, Reuser, AJ.Glycogen Storage Disease Type II: acid α-glucosidase (acid maltase) deficiency. New York: McGraw-Hill, 2006, Chapter 135.Google Scholar
van den Hout, HM, Hop, W, van Diggelen, OP, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112:332–40.CrossRefGoogle ScholarPubMed
Hagemans, ML, Winkel, LP, Van Doorn, PA, et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005;128:671–7.CrossRefGoogle ScholarPubMed
Mellies, U, Ragette, R, Schwake, C, et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001;57:1290–5.CrossRefGoogle ScholarPubMed
Katirji, B, Kesner, V, Hejal, RB, Alshekhlee, A.Teaching NeuroImage: Axial muscle atrophy in adult-onset Pompe disease. Neurology 2008;70:e36.CrossRefGoogle ScholarPubMed
Schoser, BG, Muller-Hocker, J, Horvath, R, et al. Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 2007;33:544–59.Google ScholarPubMed
Winkel, LP, Hagemans, ML, van Doorn, PA, et al. The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol 2005;252:875–84.CrossRefGoogle ScholarPubMed
van der Ploeg, AT, Reuser, AJ.Pompe's disease. Lancet 2008;372:1342–53.CrossRefGoogle ScholarPubMed
Pellegrini, N, Laforet, P, Orlikowski, D, et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J 2005;26:1024–31.CrossRefGoogle ScholarPubMed
Geel, TM, McLaughlin, PM, de Leij, LF, Ruiters, MH, Niezen-Koning, KE.Pompe disease: current state of treatment modalities and animal models. Mol Genet Metab 2007;92:299–307.CrossRefGoogle ScholarPubMed
Moser, H, Linke, T, Fensom, AH, Levade, T, Sandhoff, K.The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2006.Google Scholar
Farber, S, Cohen, J, Uzman, LL.Lipogranulomatosis; a new lipo-glycoprotein storage disease. J Mt Sinai Hosp N Y 1957;24:816–37.Google ScholarPubMed
Willis, A, Vanhuse, C, Newton, KP, Wasserstein, M, Morotti, RA.Farber's disease type IV presenting with cholestasis and neonatal liver failure: report of two cases. Pediatr Dev Pathol 2008;11:305–8.CrossRefGoogle ScholarPubMed
Devi, AR, Gopikrishna, M, Ratheesh, R, et al. Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family. J Hum Genet 2006;51:811–4.CrossRefGoogle Scholar
Bierman, S, Edgington, T, Newcomer, V, Pearson, C.Farber's disease: A disorder of mucopolysaccharide metabolism with aritcular, respiratory and neurologic manifestations. Arthritis Rheum 1966;9:620–30.CrossRefGoogle Scholar
Abul-Haj, SK, Martz, DG, Douglas, WF, Geppert, LJ.Farber's disease. Report of a case with observations on its histogenesis and notes on the nature of the stored material. J Pediatr 1962;61:221–32.CrossRefGoogle ScholarPubMed
Park, JH, Schuchman, EH.Acid ceramidase and human disease. Biochim Biophys Acta 2006;1758:2133–8.CrossRefGoogle ScholarPubMed
Yeager, AM, Uhas, KA, Coles, CD, et al. Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 2000;26:357–63.CrossRefGoogle Scholar
Ehlert, K, Roth, J, Frosch, M, et al. Farber's disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach. Ann Rheum Dis 2006;65:1665–6.CrossRefGoogle ScholarPubMed
Simell, O.Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2004.Google Scholar
Sperandeo, MP, Andria, G, Sebastio, G.Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene. Hum Mutat 2008;29:14–21.CrossRefGoogle ScholarPubMed
Santamaria, F, Parenti, G, Guidi, G, et al. Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods. Am J Respir Crit Care Med 1996;153:731–5.CrossRefGoogle ScholarPubMed
Parto, K, Svedstrom, E, Majurin, ML, Harkonen, R, Simell, O.Pulmonary manifestations in lysinuric protein intolerance. Chest 1993;104:1176–82.CrossRefGoogle ScholarPubMed
McManus, DT, Moore, R, Hill, CM, et al. Necropsy findings in lysinuric protein intolerance. J Clin Pathol 1996;49:345–7.CrossRefGoogle ScholarPubMed
Parto, K, Maki, J, Pelliniemi, LJ, Simell, O.Abnormal pulmonary macrophages in lysinuric protein intolerance. Ultrastructural, morphometric, and x-ray microanalytic study. Arch Pathol Lab Med 1994;118:536–41.Google ScholarPubMed
Kerem, E, Elpelg, ON, Shalev, RS, et al. Lysinuric protein intolerance with chronic interstitial lung disease and pulmonary cholesterol granulomas at onset. J Pediatr 1993;123:275–8.CrossRefGoogle Scholar
Douda, DN, Farmakovski, N, Dell, S, Grasemann, H, Palaniyar, N.SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance. Orphanet J Rare Dis 2009;4:29.CrossRefGoogle ScholarPubMed
Palaniyar, N, Ikegami, M, Korfhagen, T, Whitsett, J, McCormack, FX.Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension. Comp Biochem Physiol A Mol Integr Physiol 2001;129:109–27.CrossRefGoogle ScholarPubMed
Poulain, FR, Akiyama, J, Allen, L, et al. Ultrastructure of phospholipid mixtures reconstituted with surfactant proteins B and D. Am J Respir Cell Mol Biol 1999;20:1049–58.CrossRefGoogle Scholar
Ceruti, M, Rodi, G, Stella, GM, et al. Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Orphanet J Rare Dis 2007;2:14.CrossRefGoogle ScholarPubMed
Santamaria, F, Brancaccio, G, Parenti, G, et al. Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance. J Pediatr 2004;145:268–72.CrossRefGoogle Scholar
Robbesom, AA, Koenders, MM, Smits, NC, et al. Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema. Mod Pathol 2008;21:297–307.CrossRefGoogle ScholarPubMed
Pearson, GD, Devereux, R, Loeys, B, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation 2008;118:785–91.CrossRefGoogle Scholar
Habashi, JP, Judge, DP, Holm, TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117–21.CrossRefGoogle Scholar
Mizuguchi, T, Collod-Beroud, G, Akiyama, T, et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 2004;36:855–60.CrossRefGoogle ScholarPubMed
De Paepe, A, Devereux, RB, Dietz, HC, Hennekam, RC, Pyeritz, RE.Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417–26.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Rigante, D, Segni, G, Bush, A.Persistent spontaneous pneumothorax in an adolescent with Marfan's syndrome and pulmonary bullous dysplasia. Respiration 2001;68:621–4.CrossRefGoogle Scholar
Hall, JR, Pyeritz, RE, Dudgeon, DL, Haller, JA. Pneumothorax in the Marfan syndrome: prevalence and therapy. Ann Thorac Surg 1984;37:500–4.CrossRefGoogle ScholarPubMed
Gawkrodger, DJ.Marfan's syndrome presenting as bilateral spontaneous pneumothorax. Postgrad Med J 1981;57:240–1.CrossRefGoogle ScholarPubMed
Sensenig, DM, LaMarche, P.Marfan's syndrome and spontaneous pneumothorax. Am J Surg 1980;139:602–4.CrossRefGoogle ScholarPubMed
Lipton, RA, Greenwald, RA, Seriff, NS.Pneumothorax and bilateral honeycombed lung in Marfan syndrome. Report of a case and review of the pulmonary abnormalities in this disorder. Am Rev Respir Dis 1971;104:924–8.Google ScholarPubMed
Wood, JR, Bellamy, D, Child, AH, Citron, KM.Pulmonary disease in patients with Marfan syndrome. Thorax 1984;39:780–4.CrossRefGoogle ScholarPubMed
Foster, ME, Foster, DR.Bronchiectasis and Marfan's syndrome. Postgrad Med J 1980;56:718–9.CrossRefGoogle ScholarPubMed
Teoh, PC.Bronchiectasis and spontaneous pneumothorax in Marfan's syndrome. Chest 1977;72:672–3.CrossRefGoogle ScholarPubMed
Cipriano, GF, Peres, PA, Cipriano, G, Arena, R, Carvalho, AC.Safety and cardiovascular behavior during pulmonary function in patients with Marfan syndrome. Clin Genet 2010;78:57–65.CrossRefGoogle ScholarPubMed
Verbraecken, J, Paelinck, BP, Willemen, M, Van de Heyning, P, De Backer, W.Aortic root diameter and nasal intermittent positive airway pressure treatment in Marfan's syndrome. Clin Genet 2003;63:131–4.CrossRefGoogle ScholarPubMed
Cistulli, PA, Sullivan CE. Sleep apnea in Marfan's syndrome. Increased upper airway collapsibility during sleep. Chest 1995;108:631–5.CrossRefGoogle ScholarPubMed
Cistulli, PA, Sullivan, CE.Sleep-disordered breathing in Marfan's syndrome. Am Rev Respir Dis 1993;147:645–8.CrossRefGoogle ScholarPubMed
Kohler, M, Blair, E, Risby, P, et al. The prevalence of obstructive sleep apnoea and its association with aortic dilatation in Marfan's syndrome. Thorax 2009;64:162–6.CrossRefGoogle ScholarPubMed
Jacobs, AM, Toudjarska, I, Racine, A, et al. A recurring FBN1 gene mutation in neonatal Marfan syndrome. Arch Pediatr Adolesc Med 2002;156:1081–5.CrossRefGoogle ScholarPubMed
Day, DL, Burke, BA.Pulmonary emphysema in a neonate with Marfan syndrome. Pediatr Radiol 1986;16:518–21.CrossRefGoogle Scholar
Tobin, JR, Bay, EB, Humphreys, EM.Marfan's syndrome in the adult dissecting aneurysm of the aorta associated with arachnodactyly. Arch Med Interna 1947;80:475–90.CrossRefGoogle ScholarPubMed
Laurenzi, GA, Turino, GM, Fishman, AP.Bullous disease of the lung. Am J Med 1962;32:361–78.CrossRefGoogle ScholarPubMed
Sayers, CP, Goltz, RW, Mottiaz, J.Pulmonary elastic tissue in generalized elastolysis (cutis laxa) and Marfan's syndrome: a light and electron microscopic study. J Invest Dermatol 1975;65:451–7.CrossRefGoogle ScholarPubMed
Roark, JW.The Marfan syndrome: report of one case with autopsy, special histological study, and review of the literature. AMA Arch Intern Med 1959;103:123–32.CrossRefGoogle ScholarPubMed
Bolande, RP, Tucker, AS.Pulmonary emphysema and other cardiorespiratory lesions as part of the Marfan abiotrophy. Pediatrics 1964;33:356–66.Google ScholarPubMed
Reye, RD, Bale, PM.Elastic tissue in pulmonary emphysema in Marfan syndrome. Arch Pathol 1973;96:427–31.Google ScholarPubMed
Kielty, CM, Sherratt, MJ, Shuttleworth, CA.Elastic fibres. J Cell Sci 2002;115:2817–28.Google ScholarPubMed
Eldadah, ZA, Brenn, T, Furthmayr, H, Dietz, HC.Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest 1995;95:874–80.CrossRefGoogle ScholarPubMed
Matt, P, Habashi, J, Carrel, T, et al. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?J Thorac Cardiovasc Surg 2008;135:389–94.CrossRefGoogle ScholarPubMed
Neptune, ER, Frischmeyer, PA, Arking, DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407–11.CrossRefGoogle ScholarPubMed
Silverman, DI, Burton, KJ, Gray, J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995;75:157–60.CrossRefGoogle ScholarPubMed
Murdoch, JL, Walker, BA, Halpern, BL, Kuzma, JW, McKusick, VA.Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972;286:804–8.CrossRefGoogle ScholarPubMed
Germain, DP, Herrera-Guzman, Y.Vascular Ehlers-Danlos syndrome. Ann Genet 2004;47:1–9.CrossRefGoogle ScholarPubMed
Callewaert, B, Malfait, F, Loeys, B, De Paepe, A.Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 2008;22:165–89.CrossRefGoogle ScholarPubMed
Morgan, AW, Pearson, SB, Davies, S, Gooi, HC, Bird, HA.Asthma and airways collapse in two heritable disorders of connective tissue. Ann Rheum Dis 2007;66:1369–73.CrossRefGoogle ScholarPubMed
Ayres, JG, Pope, FM, Reidy, JF, Clark, TJ.Abnormalities of the lungs and thoracic cage in the Ehlers-Danlos syndrome. Thorax 1985;40:300–5.CrossRefGoogle ScholarPubMed
Cavanaugh, MJ, Cooper, DM.Chronic pulmonary disease in a child with the Ehlers-Danlos syndrome. Acta Paediatr Scand 1976;65:679–84.CrossRefGoogle Scholar
Aaby, GV, Blake, HA.Tracheobronchiomegaly. Ann Thorac Surg 1966;2:64–70.CrossRefGoogle ScholarPubMed
Watanabe, A, Kawabata, Y, Okada, O, et al. Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene. Eur Respir J 2002;19:195–8.CrossRefGoogle ScholarPubMed
Dowton, SB, Pincott, S, Demmer, L.Respiratory complications of Ehlers-Danlos syndrome type IV. Clin Genet 1996;50:510–4.CrossRefGoogle ScholarPubMed
Yost, BA, Vogelsang, JP, Lie, JT.Fatal hemoptysis in Ehlers-Danlos syndrome. Old malady with a new curse. Chest 1995;107:1465–7.CrossRefGoogle ScholarPubMed
Herman, TE, McAlister, WH.Cavitary pulmonary lesions in type IV Ehlers-Danlos syndrome. Pediatr Radiol 1994;24:263–5.CrossRefGoogle ScholarPubMed
Ishiguro, T, Takayanagi, N, Kawabata, Y, et al. Ehlers-Danlos syndrome with recurrent spontaneous pneumothoraces and cavitary lesion on chest X-ray as the initial complications. Intern Med 2009;48:717–22.CrossRefGoogle ScholarPubMed
Murray, RA, Poulton, TB, Saltarelli, MG, et al. Rare pulmonary manifestation of Ehlers-Danlos syndrome. J Thorac Imaging 1995;10:138–41.CrossRefGoogle ScholarPubMed
Kawabata, Y, Watanabe, A, Yamaguchi, S, et al. Pleuropulmonary pathology of vascular Ehlers-Danlos syndrome: spontaneous laceration, haematoma and fibrous nodules. Histopathology 2010;56:944–50.CrossRefGoogle ScholarPubMed
Corrin, B, Simpson, CG, Fisher, C.Fibrous pseudotumours and cyst formation in the lungs in Ehlers-Danlos syndrome. Histopathology 1990;17:478–9.CrossRefGoogle ScholarPubMed
Clark, JG, Kuhn, C, Uitto, J.Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies. Am Rev Respir Dis 1980;122:971–8.Google ScholarPubMed
Pepin, M, Schwarze, U, Superti-Furga, A, Byers, PH.Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000;342:673–80.CrossRefGoogle ScholarPubMed
Germain, DP.Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2007;2:32.CrossRefGoogle ScholarPubMed
Erez, Y, Ezra, Y, Rojansky, N.Ehlers-Danlos type IV in pregnancy. A case report and a literature review. Fetal Diagn Ther 2008;23:7–9.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×